Depressive Typologies and Response to Amitriptyline | The British Journal of Psychiatry | Cambridge Core (original) (raw)

Extract

The aims of this paper are to report findings from the use of an empirically derived typology to predict response of depressed patients to amitriptyline, and to compare this typological prediction with predictions from two other classifications of depressed patients, one traditional and one newer.

References

1 American Psychiatric Association (1968). Diagnostic and Statistical Manual of Mental Disorders; Second Edition, Google Scholar

2 Ball, J. R., and Kiloh, L. G. (1959). ‘A controlled trial of imipramine in treatment of depressive states.’ British Medical Journal, ii, 1052–55.Google Scholar

3 Di Mascio, A., and Shader, R. I. (1969). ‘Drug administration schedules.’ American Journal of Psychiatry, 126, 796–801.CrossRefGoogle Scholar

4 Greenblatt, M., Grosser, G. H., and Wechsler, H. (1964). ‘Differential response of hospitalized depressed patients to somatic therapy.’ American Journal of Psychiatry, 120, 935–43.CrossRefGoogle ScholarPubMed

5 Hempel, G. (1961). ‘Introduction to problems of taxonomy.’ In Field Studies in Mental Disorders, (ed. J. Zubin). New York: Grune and Stratton.Google Scholar

6 Hollister, L. E., Overall, J. E., Shelton, J., Pennington, V., Kimbell, I., and Johnson, M. (1967). ‘Drug therapy of depression: amitriptyline, perphenazine, and their combination in different syndromes.’ Archives of General Psychiatry, 17, 486–93.CrossRefGoogle ScholarPubMed

7 Kay, D. W. K., Garside, R. F., Roy, J. R., and Beamish, P. (1969). ‘ “Endogenous” and “neurotic” syndromes of depression: a 5 to 7 year follow-up of 104 cases.’ British Journal of Psychiatry, 115, 389–99.CrossRefGoogle ScholarPubMed

8 Kiloh, L. G., Ball, J. R. B., and Garside, R. F. (1962). ‘Prognostic factors in treatment of depressive states with imipramine.’ British Medical Journal, i, 1225–27.Google Scholar

10 Klerman, G. L., and Cole, J. O. (1965). ‘Clinical pharmacology of imipramine and related antidepressant compounds.’ Pharmacological Reviews, 17, 101–41.Google ScholarPubMed

11 Klerman, G. L., and Paykel, E. S. (1970). ‘Depressive pattern, social background and hospitalization.’ Journal of Nervous and Mental Disease, 150, 466–78.CrossRefGoogle ScholarPubMed

12 Klerman, G. L., Klerman, G. L., and Di Mascio, A. (1968). ‘An outpatient trial of maintenance antidepressant drug therapy and social casework psychotherapy in depressed patients.’ Research Protocol. Google Scholar

13 Mendels, J., and Cochrane, C. (1968). ‘The nosology of depression: the endogenous-reactive concept.’ American Journal of Psychiatry, 124, 1–11.CrossRefGoogle ScholarPubMed

14 Overall, J. E., and Gorham, D. R. (1962). ‘The brief psychiatric rating scale.’ Psychological Reports, 10, 799–812.CrossRefGoogle Scholar

15 Overall, J. E., Hollister, L. E., Johnson, M., and Pennington, V. (1966). ‘Nosology of depression and differential response to drugs.’ Journal of the American Medical Association, 195, 946–8.Google ScholarPubMed

16 Overall, J. E., and Klett, C. J. (1971). Applied Multivariate Analysis. McGraw-Hill.Google Scholar

17 Paykel, E. S. (1971). ‘Classification of depressed patients; a cluster-analysis-derived grouping.’ British Journal of Psychiatry, 118, 275–88.CrossRefGoogle ScholarPubMed

18 Paykel, E. S. (1972). ‘Correlates of a depressive typology’. Archives of General Psychiatry. .CrossRefGoogle Scholar

19 Paykel, E. S. Klerman, G. L., and Prusoff, B. (1970). ‘Treatment setting and clinical depression’. Archives of General Psychiatry, 22, 11–21.CrossRefGoogle ScholarPubMed

20 Paykel, E. S. Klerman, G. L., Prusoff, B. Haskell, D., and DiMascio, A. (1970). ‘Clinical response to amitriptyline among depressed women.’ Proceedings of Prediction Section, Eighth Annual Meeting, American College of Neuropsychopharmacology, .Google Scholar

21 Paykel, E. S. Klerman, G. L., and Prusoff, B. ‘The endogenous-neurotic continuum in depression: rater independence and factor distributions.’ (1971). Journal of Psychiatric Research. 8, 73–90.CrossRefGoogle ScholarPubMed

22 Raskin, A., Schulterbrandt, J. G., Reatig, N., and McKeon, J. J. (1970). ‘Differential response to chlorpromazine, imipramine, and placebo.’ A study of subgroups of hospitalized depressed patients. Archives of General Psychiatry, 23, 164–73.CrossRefGoogle ScholarPubMed

23 Wilder, J. (1966). ‘Basimetric approach to psychiatry.’ In American Handbook of Psychiatry, Vol. 3, , pp. 333–43 (ed. S. Arieti). New York: Basic Books.Google Scholar

24 Wittenborn, J. R. (1969). ‘Diagnostic classification and response to imipramine.’ In Psychotropic Drug Response, , pp. 198–227 (ed. P. R. A. May, and J. R. Wittenborn). Springfield, Illinois: Charles C. Thomas.Google Scholar

25 Wittenborn, J. R. Kiremetci, N., and Weber, E. S. P. (1970). ‘Correlates of change among depressed hospitalized females.’ .Google Scholar

26 Wittenborn, J. R. Plante, M., Burgess, F., and Maurer, H. (1962). ‘A comparison of imipramine, electroconvulsive therapy and placebo in the treatment of depression.’ Journal of Nervous and Mental Disease, 135, 131–7.CrossRefGoogle Scholar

27 World Health Organization (1968). International Classification of Diseases, .Google Scholar

28 Wyshak, G. (1970). ‘Modification of multiple regression when an independent variable is subtracted from the dependent variable.’ .Google Scholar